September 14, 2026 – PRESSADVANTAGE –

Premier Allergy & Asthma has officially announced the expansion of its diagnostic and clinical management protocols for patients with chronic spontaneous and inducible urticaria across its Ohio facilities. Available as of fall 2026, the updated immunological evaluation framework expands local clinical capacity for individuals searching for a hives specialist near me, offering structured diagnostic workups, biologic therapy administration, and evidence-based management of persistent dermatological allergic conditions.

Under the clinical direction of board-certified allergist Dr. David M. Hauswirth, the practice introduced these expanded protocols to address the diagnostic and therapeutic challenges associated with chronic urticaria. Commonly referred to as hives, chronic urticaria is defined by the recurring presence of transient, intensely pruritic erythematous wheals, angioedema, or both, persisting for six weeks or longer. Because the condition can stem from complex mast cell degranulation triggered by autoimmune mechanisms, physical stimuli, or underlying systemic conditions, obtaining an accurate diagnosis requires comprehensive medical evaluation rather than simple over-the-counter symptom suppression.

According to clinical practice guidelines published by the American Academy of Allergy, Asthma & Immunology (AAAAI) and the Joint Task Force on Practice Parameters, managing chronic urticaria follows a stepped, evidence-based pharmacological pathway. Initial management centers on second-generation, non-sedating H1-antihistamines, which block histamine receptors on vascular endothelial cells and sensory nerves. For refractory cases where standard or high-dose H1-antihistamine therapy fails to achieve complete symptom control, clinical consensus guidelines recommend step-up treatment utilizing targeted biologic therapies, such as anti-IgE monoclonal antibodies, to prevent mast cell and basophil activation.

Diagnostic protocols integrated across the clinic’s facilities begin with a detailed clinical history, physical examination, and targeted laboratory testing to rule out underlying systemic autoimmune diseases, thyroid dysfunction, or cutaneous vasculitis. Digital diagnostic tracking and disease activity scores, such as the Urticaria Activity Score (UAS7), are utilized during clinical visits to quantify daily wheal counts and itch severity, enabling clinicians to objectively monitor treatment response and adjust medication dosages appropriately over time.

In addition to pharmacological intervention, the expanded protocols incorporate comprehensive patient education regarding non-pharmacological trigger management. Clinical staff provide individualized counseling on identifying and avoiding known physical triggers, such as pressure, temperature extremes, vibration, or solar exposure in cases of physical urticarias. Caregivers and patients also receive clinical guidance on managing potential exacerbating factors, including emotional stress, systemic viral infections, non-steroidal anti-inflammatory drug (NSAID) usage, and tight-fitting clothing that creates mechanical friction against sensitive skin layers. Educational resources also detail optimal skincare strategies, such as using gentle, fragrance-free cleansers and applying cool compresses to soothe active cutaneous eruptions.

Furthermore, the practice maintains structured ongoing monitoring for patients presenting with co-occurring angioedema, a condition characterized by deeper dermal and subcutaneous tissue swelling that frequently accompanies severe urticaria. Clinical protocols establish immediate triage and management guidelines to differentiate localized cutaneous angioedema from rare, life-threatening laryngeal edema that requires emergency hospital intervention, ensuring high standards of patient safety throughout treatment. Clinicians work closely with patients to document the frequency, duration, and anatomical distribution of swelling episodes, ensuring that individuals who exhibit signs of mast cell-mediated or bradykinin-mediated airway compromise are equipped with emergency action plans and appropriate auto-injectable medications when indicated.

By integrating advanced immunological diagnostics, biologic therapy management, and stepped treatment algorithms alongside routine allergy care, the practice aims to deliver comprehensive care tailored to complex dermatological and allergic conditions. Ohio residents seeking specialized diagnostic workups or evidence-based management plans from a hives specialist near me can access direct telephone scheduling and educational clinical resources through Premier Allergy & Asthma’s official regional offices.

###

For more information about Premier Allergy and Asthma, contact the company here:

Premier Allergy and Asthma
Premier Allergy and Asthma
(614) 524-5779
appt@ohallergy.com

Media gallery

About The Author
PressAdvantage